Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide: Cellular localization and role of endogenous tumor necrosis factor-α

American Journal of Pathology

Volumn 150, Issue 2, 1997, Pages 579-590

  Fearns, Colleen ^a   Loskutoff, David J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; ENDOTHELIUM CELL; ENDOTOXEMIA; GENE EXPRESSION; HEART INFARCTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED STRAINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031016324     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Schleef RR, Higgins DL, Pillemer E, Levitt LJ: Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor, J Clin Invest 1989, 83: 1747-1752
2. Dieval J, Nguyen G, Gross S, Delobel J, Kruithof EKO: A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1. Blood 1991. 77:528-532
3. Fay WP, Shapiro AD, Shih JL, Schleef RR, Ginsburg D: Complete deficiency of plasminogen activator inhibitor type 1 due to a frame-shift mutation. N Engl J Med 1992. 327:1729-1733
4. Lee MH, Vosburgh E: Anderson K, McDonagh J: Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding. Blood 1993, 81:2357-2362
5. Nilsson IM, Ljungner H, Tengborn L: Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J 1985, 290:1453-1455
6. Hamsten A, DeFaire U, Walldius G, Dahlen G, Szamosa C, Landou C, Blomback M, Wiman B: Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction, Lancet 1987, ii:3-9
7. Vaughan DE, Declerck PJ, Van Houtte E, De Mol M, Collen D: Reactivated recombinant plasminogen activator inhibitor 1 (rPAI-1) effectively prevents thrombolysis in vivo. Thromb Haemost 1992, 68:60-63
8. Levi M, Biemond BJ, Van Zonneveld AJ, ten Gate JW, Pannekoek H: Inhibition of plasminogen activator inhibitor 1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation 1992, 85:305-312
9. Colucci M, Paramo JA, Collen D: Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation, J Clin Invest 1985, 75:818-824
10. Quax PHA, van den Hoo'gen CM, Verheijen JH, Padro T, Zeheb R, Gelehrter TD, van Berkel TJC, Kuiper J, Emeis JJ: Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues In vivo. J Biol Chem 1990, 265:15560-15563
11. Suffredini AF, Harpel PC, Parrillo JE: Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989, 320:1165-1172
12. van Deventer SJH, Buller HR, ten Gate JW, Aarden LA, Hack CE, Sturk A: Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways, Blood 1990, 76:2520-2526
13. Biemond BJ, Levi M, ten Gate H, van der Poll T, Buller HR, Hack CE, ten Gate JW: Plasminogen activator and plasminogen activator inhibitor 1 release during experimental endotoxaemia in chimpanzees: effect of inter- ventions in the cytokine and coagulation cascades, Clin Sci 1995, 88:587-594
14. Sawdey MS, Loskutoff DJ: Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β, J Clin Invest 1991, 88:1346-1353
15. Dinarello CA: The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991, 163:1177-1184
16. Alexander HR, Doherty GM, Buresh CM, Venzon DJ, Norton JA: A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxernia in mice. J Exp Med 1991, 173:1029-1032
17. 2 In sepsis: studies in nonhuman primates after interleukin-1α administration and during lethal bacteremia, Blood 1995, 86:1027-1034
18. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985, 229:869-871
19. Remick DG, Strieter RM, Eskandari MK, Nguyen DT, Genord MA, Raiford CL, Kunkel SL; Role of tumor necrosis factor-α in lipopolysaccharide-induced pathological alterations, Am J Pathol 1990, 136:49-60
20. Konkle BA, Schuster SJ, Kelly MD, Harjes K, Hassett DE, Bohrer M, Tavassoli M: Plasminogen activator inhibitor-1 messenger RNA expression is induced in rat hepatocytes in vivo by dexamethasone. Blood 1992, 79:2636-2642
21. van der Poll T, Levi M, Buller HR, van Deventer SJH, de Boer JP, Hack CE, ten Gate JW: Fibrinolytic response to tumor necrosis factor in healthy subjects, J Exp Med 1991, 174:729-732
22. van Hinsbergh VWM, Kooistra T, van den Berg EA, Princen HMG, Fiers W, Emeis JJ: Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells In vitro and in rats in vivo. Blood 1988, 72:1467-1473
23. Loskutoff DJ: Regulation of PAI-1 gene expression, Fibrinolysis 1991,5:197-206
24. Keeton MR, Egucni Y, Sawdey MS, Ahn C, Loskutoff DJ: Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue, Am J Pathol 1993, 142:59-70
25. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A: Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 1986, 83:1670-1674
26. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem 1987, 162:156-159
27. Schleef RR, Sinha M, Loskutoff DJ: An immunoradiometric assay to measure the binding of a specific inhibitor to tissue-type plasminogen activator. J Lab Clin Med 1985, 106:408-415
28. Austyn JM, Gordon S: F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981, 11:805-815
29. Hume DA, Gordon S: Mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80, J Exp Med 1983, 157:1704-1709
30. Lepay DA, Nathan CF, Steinman RM, Murray HW, Cohn ZA: Murine Kupffer cells: mononuclear phagocytes deficient in the generation of reactive oxygen intermediates. J Exp Med 1985, 161:1079-1096
31. Bauss F, Droge W, Mannel DN: Tumor necrosis factor mediates endotoxic effects in mice. Infect Immun 1987, 55:1622-1625
32. Decker K: Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990, 192:245-261
33. Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL: in vivo biological and immunohistochemical analysis of interleukin-1α, β, and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am J Pathol 1991, 138:395-402
34. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/ tumor necrosis factor from human monocytes. J Immunol Methods 1986, 95:99-105
35. Samad F, Yamamoto K, Loskutoff DJ: Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo: induction by tumor necrosis factor-a and lipopolysaccharide. J Clin Invest 1996, 97:37-46
36. Thornton AJ, Bruzdzinski CJ, Raper SE, Gelehrter TD: Plasminogen activator inhibitor-1 is an immed ate early response gene in regenerating rat liver, Cancer Res 1994, 54:1337-1343
37. Schneiderman J, Sawdey M, Craig H, Thinnes T, Bordin G, Loskutoff DJ: Type 1 plasminogen activator inhibitor gene expression following partial hepatectomy, Am J Pathol 1993, 143:753-762
38. Podor TJ, Hirsh J, Gelehrter TD, Zeheb R, Torry D, Guigoz Y, Sierra F, Gauldie J: Type 1 plasminogen activator inhibitor is not an acute phase reactant in rats: lack of IL-6 and hepatocyte-dependent synthesis, J Immunol 1993, 150:225-235
39. Fujii S, Sawa H, Saffitz JE, Lucore CL, Sobel BE: Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis in vivo. Circulation 1992, 86:2000-2010
40. Lucore CL, Fujii S, Wun T, Sobel BE, Billadello JJ: Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. J Biol Chem 1988, 263:15845-15848
41. Busso N, Nicodeme E, Chesne C, Guillouzo A, Belin D, Hyafil F: Urokinase and type 1 plasminogen activator inhibitor production by normal human hepatocytes: modulation by inflammatory agents. Hepatology 1994, 20:186-190
42. Kooistra T, Bosma PJ, Tons HAM: Van den Berg AP, Meyer P, Princen HMG: Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. Thromb Haemost 1989, 62:723-728
43. Thornton AJ, Gelehrter TD: Human hepatocytes express the gene for type 1 plasminogen activator inhibitor (PAI-1) in vivo. Fibrinolysis 1995, 9:9-15
44. Aillaud MF, Juhan-Vague I, Alessi MC, Marecal M, Vinson MF, Arnoud C, Vague PH, Collen D: Increased PA-inhibitor levels in the postoperative period: no cause-effect relation with increased cortisol. Thromb Haemost 1985, 54:466-468
45. Kluft C, Verheijen JH, Jie AFH, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AD: The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma, Scand J Clin Lab Invest 1985,45:605-610
46. Kruithof EKO, Gudinchet A, Bachmann F: Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states, Thromb Haemost 1988, 59:7-12
47. Schwartz BS, Bradshaw JD: Regulation of plasmino- gen activator inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes, J Biol Chem 1992, 267:7089-7094
48. Luster MI, Germolec DR, Yoshida T, Kayama F, Thompson M: Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 1994, 19:480-488
49. Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF, Cerami A; Antibodies to cachectin/tumor necrosis factor reduce interleukin Iβ and interleukin 6 appearance during lethal bacteremia. J Exp Med 1989, 170:1627-1633
50. Arndt A, Murphy P, Hart DA: Human HuH-7 hepatoma cells express urokinase and plasminogen activator inhibitor-1; identification, characterization and regulation by inflammatory mediators. Biochim Biophys Acta 1992, 1138:149-156
51. Healy AM, Gelehrter TD: Induction of plasminogen activator inhibitor-1 in HepG2 human hepatoma cells by mediators of the acute phase response. J Biol Chem 1994, 269:19095-19100
52. Shirahama M, Ishibashi H, Tsuchiya Y, Kurokawa S, Hayashida K, Okumura Y, Niho Y: Kupffer cells may autoregulate interleukin 1 production by producing interleukin 1 inhibitor and prostaglandin E2. Scand J Immunol 1988, 28:719-725
53. Emeis JJ, Hoekzema R, De Vos AF: Inhibiting interleukin-1 and tumor necrosis factor- does not reduce induction of plasminogen activator inhibitor type-1 by endotoxin in rats In vivo. Blood 1995, 85:115-120